EFFECT OF REPEATED METHAMPHETAMINE ADMINISTRATIONS ON DOPAMINE AND GLUTAMATE EFFLUX IN RAT PREFRONTAL CORTEX

被引:92
作者
STEPHANS, SE
YAMAMOTO, BK
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PSYCHIAT,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,PROGRAM BASIC & CLIN NEUROSCI,CLEVELAND,OH 44106
关键词
METHAMPHETAMINE; CORTEX; STRIATUM; GLUTAMATE; DOPAMINE; MICRODIALYSIS;
D O I
10.1016/0006-8993(95)00938-M
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pretreatment with psychostimulants such as methamphetamine (METH) results in augmented mesostriatal dopamine transmission upon a challenge administration of the drug. This effect can be blocked by dopamine antagonists and excitatory amino acid antagonists. However, no direct comparisons have been made with respect to the effects of a low-dose pretreatment regimen of METH on impulse and transporter-mediated dopamine release or to what extent glutamate release is altered by a pretreatment regimen with METH. The purpose of this study was to examine dopamine and glutamate efflux in the prefrontal cortex and striatum in rats pretreated with METH following either high potassium (80 mM) infusion or after a systemic injection of a low dose of METH. Extracellular dopamine and glutamate concentrations in the prefrontal cortex and striatum were measured in vivo by microdialysis. Potassium infusion increased extracellular dopamine and glutamate concentrations to a greater extent in the prefrontal cortex than in the striatum of METH-pretreated rats compared to saline-pretreated controls. A low dose METH challenge significantly increased extracellular dopamine but not glutamate concentrations in both prefrontal cortex and striatum of all animals. Moreover, the acute METH-induced increase in cortical dopamine efflux was significantly greater in rats pretreated with METH. Overall, these data are the first evidence that repeated METH administrations can enhance cortical glutamate efflux and indicate that a low dose pretreatment regimen of METH enhances dopamine transmission in the prefrontal cortex through both transporter and depolarization-induced mechanisms.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 57 条
[1]  
Abercrombie, Keefe, DiFrischia, Zigmond, Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens and medial frontal cortex, J. Neurochem., 52, pp. 1655-1658, (1989)
[2]  
Akimoto, Hamamura, Kazahaya, Akiyama, Otsuki, Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine — an in vivo dialysis study in freely moving rats, Brain Res., 507, pp. 344-346, (1990)
[3]  
Antelman, Eichler, Black, Kocan, Interchangeability of stress and amphetamine in sensitization, Science, 207, pp. 329-331, (1980)
[4]  
Bannon, Roth, Pharmacology of mesocortical dopamine neurons, Pharmacol. Rev., 35, pp. 53-68, (1983)
[5]  
Butcher, Fairbrother, Kelly, Arbuthnott, Amphetamine-induced dopamine release in the rat striatum: An in vivo microdialysis study, J. Neurochem., 50, pp. 346-355, (1988)
[6]  
Castaneda, Becker, Robinson, The long term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro, Life Sci., 42, pp. 2447-2456, (1988)
[7]  
Donzanti, Yamamoto, An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates, Life Sci., 43, pp. 913-922, (1988)
[8]  
Hamamura, Akiyama, Akimoto, Kashihara, Okumura, Ujike, Otsuki, Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis, Brain Res., 546, pp. 40-46, (1991)
[9]  
Hamamura, Fibiger, Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats, Eur. J. Pharmacol., 237, pp. 65-71, (1993)
[10]  
Herman, Stinus, Le Moal, Repeated stress increases locomotor response to amphetamine, Psychopharmacology, 84, pp. 431-435, (1984)